Hillstream Biopharma Inc (HILS)

NASDAQ
0.91
+0.03(+3.40%)
After Hours
0.89
-0.02(-2.19%)
- Real-time Data
  • Volume:
    16,967
  • Day's Range:
    0.86 - 0.93
  • 52 wk Range:
    0.30 - 2.65

HILS Overview

Prev. Close
0.88
Day's Range
0.86-0.93
Revenue
-
Open
0.86
52 wk Range
0.3-2.65
EPS
-0.749
Volume
16,967
Market Cap
10.48M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
3,202,174
P/E Ratio
-1.18
Beta
0.466
1-Year Change
-37.67%
Shares Outstanding
11,514,144
Next Earnings Date
-
What is your sentiment on Hillstream Biopharma?
or
Market is currently closed. Voting is open during market hours.

Hillstream Biopharma Inc Company Profile

Hillstream Biopharma Inc Company Profile

Hillstream BioPharma, Inc. (HBI) is a pre-clinical biotechnology company. The Company is engaged in developing therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for treatment-resistant cancers. The Company’s lead product candidate is HSB-1216, an IMCD modulator, targeting a variety of solid tumors. The drug HSB-1216 was found to reduce tumor in burden treatment resistant cancers, including triple negative breast cancer and epithelial carcinomas. The Company uses Quatramer, a tumor targeting platform, to enhance the uptake of HSB-1216 in the tumor microenvironment (TME). Its Trident Artificial Intelligence, an artificial intelligence precision medicine platform used to identify biomarkers in clinical programs to target specific patient segments. The Company’s pipeline includes HSB-1216, HSB-888, HSB-510 and HSB-114. HSB-1216 pipeline is a novel inducer of iron-mediated cell death.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralNeutralNeutral
Technical IndicatorsBuyBuySellStrong SellNeutral
SummaryStrong BuyBuyNeutralSellNeutral